Urinalysis Market Size, Share, Trends, Industry Analysis Report: By Product (Instrument and Consumables), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034

The urinalysis market size is expected to reach USD 11,117.34 Million by 2034, according to a new study by Polaris Market Research. The report “Urinalysis Market Size, Share, Trends, Industry Analysis Report: By Product (Instrument and Consumables), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The urinalysis market encompasses diagnostic testing of urine samples to detect and monitor various medical conditions, including kidney disorders, urinary tract infections, diabetes, and metabolic diseases. The market is experiencing steady growth, driven by the rising prevalence of chronic diseases, increasing adoption of point-of-care testing (POCT), and advancements in automated urinalysis systems. Emerging technologies, such as AI-powered diagnostics and biomarker-based testing, present significant opportunities for innovation. Additionally, the expansion of healthcare infrastructure in emerging markets and the growing demand for digital urinalysis solutions integrated with electronic health records (EHR) are further supporting urinalysis market expansion. Regulatory advancements and the increasing use of disposable consumables to enhance test reliability are also shaping market trends.

Urinalysis Market Report Highlights

The consumables segment, based on product, holds a larger share of the urinalysis market revenue due to the high and repetitive demand for reagent strips and test kits in diagnostic laboratories and point-of-care testing. The growing preference for disposable consumables to prevent cross-contamination is further driving its growth.

By application, the disease screening segment dominates the market, driven by the increasing prevalence of chronic conditions such as diabetes and kidney diseases, necessitating routine urinalysis for early detection and monitoring. The rising burden of urinary tract infections (UTIs) and metabolic disorders is further contributing to its expansion.

North America dominates the urinalysis market share, due to advanced healthcare infrastructure, high adoption of automated urinalysis systems, and a growing elderly population requiring frequent diagnostic testing. Asia Pacific is witnessing the highest growth, supported by increasing healthcare investments, rising awareness of early disease detection, and the expansion of diagnostic facilities in emerging economies.

Abbott Laboratories; ACON Laboratories, Inc.; ARKRAY, Inc.; Becton, Dickinson and Company (BD); Bio-Rad Laboratories, Inc.; Cardinal Health, Inc.; Danaher Corporation; Eiken Chemical Co., Ltd.; EKF Diagnostics Holdings plc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; Sysmex Corporation; Thermo Fisher Scientific Inc.; and 77 Elektronika Kft.

Polaris Market Research has segmented the urinalysis market report on the basis of product, application, and region:

By Product Outlook (Revenue USD Million, 2020–2034)

Instrument

Consumables

By Application Outlook (Revenue USD Million, 2020–2034)

Disease Screening

Fertility & Pregnancy Testing

Others

By End Use Outlook (Revenue USD Million, 2020–2034)

Hospitals

Clinical Laboratories

Home Care

Research and Academics

Others

By Regional Outlook (Revenue USD Million, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America